Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation

about

Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation

Item

http://www.wikidata.org/entity/Q36241697

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Response-Guided Therapy for He ...... sy after Liver Transplantation

@ast

Response-Guided Therapy for He ...... sy after Liver Transplantation

@en

type

Item

label

Response-Guided Therapy for He ...... sy after Liver Transplantation

@ast

Response-Guided Therapy for He ...... sy after Liver Transplantation

@en

prefLabel

Response-Guided Therapy for He ...... sy after Liver Transplantation

@ast

Response-Guided Therapy for He ...... sy after Liver Transplantation

@en

P1476

Response-Guided Therapy for He ...... sy after Liver Transplantation

@en

P2093

Hae Won Lee

http://www.w3.org/2001/XMLSchema#string

Kwang-Woong Lee

http://www.w3.org/2001/XMLSchema#string

Kyung-Suk Suh

http://www.w3.org/2001/XMLSchema#string

Suk-Won Suh

http://www.w3.org/2001/XMLSchema#string

P2860

Strategies to reduce hepatitis C virus recurrence after liver transplantation

Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Challenges of recurrent hepatitis C in the liver transplant patient

Diagnosis, management, and treatment of hepatitis C: an update

Risk factors for hepatitis C virus infection among Koreans according to the hepatitis C virus genotype.

A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy.

Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis.

Grading and staging systems for inflammation and fibrosis in chronic liver diseases.

PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.

P304

1577-1583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3346/JKMS.2015.30.11.1577

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283334070

http://www.w3.org/2001/XMLSchema#string

P698

26539000

http://www.w3.org/2001/XMLSchema#string

P932

4630472

http://www.w3.org/2001/XMLSchema#string